youtube linkedin twitter facebook

Company news

Oxford Optronix in South America. Guest post by Petra Mayr, International Product Manager

11th June 2018

Oxford Optronix Ltd. and ADInstruments do Brasil  Ltda. recently agreed on terms for the distribution and support of Oxford Optronix’ product range across the territories of Brazil, Mexico, Columbia, Chile, Argentina and Panama.  

And so, earlier this month I travelled to São Paulo to meet with and provide product training to the team at ADInstruments do Brasil. 

Based in the iconic city of São Paulo, ADInstruments do Brasil will be responsible for sales and after-sales support on our behalf across much of South America, with a primary focus on our OxyLite™ / OxyFlo™ tissue vitality monitors and on our most recently launched product, the HypoxyLab™ workstation system for hypoxia-related cell biology research. 

Part of the team at ADInstruments do Brasil, (left to right: Leopoldo, Leila, Tatiana, myself and Patricia)

It was an immensely enjoyable and rewarding experience to meet and train the team at their offices. I was so welcomed and supported by them throughout my stay; therefore I would like to say a very special thanks to everyone at ADInstruments for organizing everything so perfectly! You are a great team and I am really looking forward to working with you in the future. 

My hosts involved me in visits to both existing customers and to prospective scientists at institutes and universities in and around São Paulo. 

Leila, Tatiana and Leopoldo in front of the Institute of Biomedical Sciences, São Paulo University

The Medical School of São Paulo University

Escola de Educação Física e Esporte de Ribeirão Preto - USP

As this was my very first time in Brazil I treated myself to a couple of days of sightseeing to explore Minas Gerais region and learn a little more about the people and history of Brazil.. 

A technicolour of Brazilan delights..

The spectacular church of São Francisco de Assis in São João del Rei



News Archive




11th April 2019
WellBeing™ clinical trials commence

5th February 2019
Article highlight

2nd January 2019
Happy New Year!